Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services source : Www.adnas.com save search
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Published: 2023-09-06 (Crawled : 14:00) - adnas.com
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 4.38%
H: 2.21%
C: -3.03%
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -1.55%
H: 2.36%
C: 0.0%
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
Published: 2023-08-29 (Crawled : 20:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 7.09%
H: 0.0%
C: -7.35%
dna
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
Published: 2023-08-23 (Crawled : 15:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -0.74%
H: 14.18%
C: 8.21%
patent mrna
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
Published: 2023-08-10 (Crawled : 21:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -4.0%
H: 1.49%
C: -7.14%
update dna financial results
APDN to Report FQ3’23 Financial Results; Investor Conference Call/Webcast 8/10
Published: 2023-08-07 (Crawled : 16:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 0.61%
H: 0.3%
C: -4.88%
conference report financial
APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
Published: 2023-07-18 (Crawled : 14:20) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: -3.73%
mrna
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
Published: 2023-07-13 (Crawled : 13:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 7.09%
H: 24.26%
C: 4.41%
platform
APDN to Present at Upcoming Healthcare Investor Conference
Published: 2023-06-08 (Crawled : 15:20) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -1.86%
H: 1.15%
C: -5.06%
conference
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
Published: 2023-05-11 (Crawled : 23:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 0.0%
H: 2.78%
C: -0.93%
update dna financial results
APDN to Report FQ2’23 Financial Results; Investor Conference Call/Webcast 5/11
Published: 2023-05-03 (Crawled : 19:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -0.53%
H: 2.46%
C: 0.54%
conference report financial
CertainT® Featured in NY Times Re: Need for Transparency and Compliance
Published: 2023-04-07 (Crawled : 18:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
| Email alert
Add to watchlist
certaint
APDN Milestone: Largest Single Large-Scale linearDNA™ Shipment to Date
Published: 2023-03-29 (Crawled : 15:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 3.64%
H: 2.63%
C: -1.75%
APDN Submits Validation Package to NYS DOH for Approval of PGx Assay
Published: 2023-03-22 (Crawled : 15:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 0.0%
H: 11.54%
C: 10.58%
approval
APDN to Report Q1 FY’23 Financial Results; Investor Conference Call/Webcast 2/9
Published: 2023-02-02 (Crawled : 15:20) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 3.36%
H: 0.0%
C: -3.9%
conference report financial
Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
Published: 2023-01-05 (Crawled : 16:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -1.23%
H: 20.31%
C: 3.12%
vaccine
APDN to Report FY’22 Q4 and Year End Financial Results
Published: 2022-12-12 (Crawled : 16:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: 2.88%
H: 9.45%
C: 3.5%
report year financial results
APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in NY
Published: 2022-10-24 (Crawled : 14:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -3.11%
H: 2.67%
C: -5.88%
dna capacity
APDN Receives Largest Single Purchase Order for LinearDNA To Date
Published: 2022-10-10 (Crawled : 14:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -2.42%
H: 96.69%
C: 75.21%
order
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
Published: 2022-09-30 (Crawled : 14:00) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -0.82%
H: 11.56%
C: -6.61%
candidate vaccine virus trial
Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
Published: 2022-09-30 (Crawled : 13:20) - adnas.com
APDN | $0.3461 3.93% 3.79% 130K
|
Commercial Services
|
| O: -0.82%
H: 11.56%
C: -6.61%
candidate vaccine virus trial
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.